Chronic obstructive pulmonary disease
Conditions
Interventions
A:PIFR-based optimized inhalation therapy
Sponsors
Zhongshan Hospital, Fudan University
Eligibility
Sex/Gender
All
Age
35 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1 Aged 35-80 years. 2 In patients with moderate and above copd with clear diagnosis of lung function, I.E. FEV1/FVC<70% after inhalation of bronchial dilatants, and<80% expected value of FEV1%. 3 It is expected that the follow-up will be completed for one year. 4 Be able to sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1 Bronchial asthma, pulmonary fibrosis, bronchial dilation, and other lung diseases; or hypertension, heart disease, chronic liver and kidney disease, diabetes, chronic gastrointestinal diseases, malignant tumors, critically ill patients. 2 Mental state does not match the observer or the person with cognitive impairment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Errors in Inhaler use;CID (clinically important Deterioration); | — |
Secondary
| Measure | Time frame |
|---|---|
| Satisfaction with inhaler;CAT score;mMRC score;6-minite walking time;COPD-related cost; | — |
Countries
China
Contacts
Public ContactJing Zhang
Zhongshan Hospital, Fudan University
Outcome results
None listed